文献速递癫痫

癫痫患者自杀的临床危险因素:一项全国性人群病例对照研究

Clinical Risk Factors for Suicide in Persons With Epilepsy: A Nationwide Population-Based Case-Control Study.
PubMed 文献 · Neurology · 2026-11-11

该研究在瑞典开展全国性病例对照研究,纳入111例自杀死亡癫痫患者和1147例对照,评估临床特征与自杀风险的关系。酒精滥用、其他物质滥用、独居、近期全面性强直-阵挛发作、结构或未知病因及用药不依从与自杀风险升高相关,抗癫痫发作药物治疗与较低风险相关。

要点

  • 酒精滥用和其他物质滥用的关联强于抑郁和焦虑障碍。
  • 过去一年4-10次全面性强直-阵挛发作风险最高(OR 5.01)。
  • 抗癫痫发作药物治疗与较低自杀风险相关,不依从与较高风险相关。

核心结论

  • 癫痫患者存在独特的自杀风险特征,酒精和物质滥用、独居、发作负担、用药不依从及结构或未知病因是关键危险因素。

研究设计与样本

  • 在瑞典开展的全国性病例对照研究,通过全国登记识别癫痫患者,癫痫诊断经病历复核验证,自杀病例经尸检报告验证。
  • 共纳入111例自杀死亡病例和1147例对照,使用条件 logistic 回归估计 OR 及95%CI。

主要发现

  • 自杀病例平均癫痫发病年龄为20岁,35%为女性。
  • 酒精滥用 OR 11.81(95%CI 6.25-22.30),其他物质滥用 OR 10.71(95%CI 4.52-25.38),抑郁 OR 2.94(95%CI 1.56-5.53),焦虑障碍 OR 2.93(95%CI 1.57-5.44)。
  • 独居 OR 2.59(95%CI 1.58-4.26)。
  • 过去一年4-10次全面性强直-阵挛发作 OR 5.01(95%CI 2.2-11.3)。
  • 结构病因 OR 3.07(95%CI 1.0-9.5),未知病因 OR 8.80(95%CI 2.9-27.1)。

临床怎么用

  • 作者认为,筛查物质滥用和改善发作控制可能有助于自杀预防。

局限性

  • 病例数量有限。
  • 既往自杀行为信息不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Individuals with epilepsy face an elevated risk of suicide, but risk factors for suicide remain incompletely understood. We conducted a nationwide case-control study in Sweden to investigate clinical characteristics associated with suicide risk in persons with epilepsy. METHODS: Persons with epilepsy were identified through Swedish nationwide registers, with epilepsy diagnoses validated through medical record review. Cases were individuals who died by suicide between 2006 and 2011, validated through autopsy reports, and controls were derived from the source population using similar validation procedures. Characteristics included epilepsy type, etiology, tonic-clonic seizure (TCS) frequency, antiseizure medication (ASM) treatment, living conditions, and psychiatric comorbidity. Odds ratios (ORs) with 95% CIs were estimated using conditional logistic regression. RESULTS: The study included 111 suicide cases and 1,147 controls. Suicide cases had a mean age at epilepsy onset of 20 years, and 35% were female. Alcohol abuse (OR 11.81, 95% CI 6.25-22.30) and other substance abuse (OR 10.71, 95% CI 4.52-25.38) showed stronger associations than depression (OR 2.94, 95% CI 1.56-5.53) and anxiety disorders (OR 2.93, 95% CI 1.57-5.44). Living alone was associated with increased risk (OR 2.59, 95% CI 1.58-4.26). Recent TCS showed a dose-response relationship, with the highest risk among individuals experiencing 4-10 TCS in the preceding year (OR 5.01, 95% CI 2.2-11.3). Structural and unknown epilepsy etiologies were associated with elevated risk (OR 3.07, 95% CI 1.0-9.5 and OR 8.80, 95% CI 2.9-27.1, respectively). ASM treatment was associated with lower suicide risk (monotherapy OR 0.51, 95% CI 0.27-0.95; polytherapy OR 0.21, 95% CI 0.1-0.5), and nonadherence was associated with higher risk (OR 3.02, 95% CI 1.8-5.1). DISCUSSION: This study identified a distinct risk profile for suicide in persons with epilepsy, highlighting alcohol and substance abuse, living alone, seizure burden, nonadherence, and structural or unknown etiologies as key risk factors. The stronger associations for substance abuse may reflect characteristics specific to epilepsy populations and the focus on completed suicide. Screening for substance abuse and improved seizure control may contribute to suicide prevention. Major limitations include the modest number of cases and incomplete information on prior suicidal behavior.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Melin S, Tomson T, Sveinsson O, et al. Clinical Risk Factors for Suicide in Persons With Epilepsy: A Nationwide Population-Based Case-Control Study. Neurology. 2026. PMID: 43013790. doi:10.1212/WNL.0000000000218768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。